Usefulness of Coronary Artery Calcium Score to Rule Out Obstructive Coronary Artery Disease Before Transcatheter Aortic Valve Implantation.


Journal

The American journal of cardiology
ISSN: 1879-1913
Titre abrégé: Am J Cardiol
Pays: United States
ID NLM: 0207277

Informations de publication

Date de publication:
15 11 2022
Historique:
received: 25 05 2022
revised: 02 07 2022
accepted: 11 07 2022
pubmed: 18 9 2022
medline: 19 10 2022
entrez: 17 9 2022
Statut: ppublish

Résumé

Pretranscatheter aortic valve implantation (pre-TAVI) coronary evaluation using computed tomography coronary angiography (CTA) remains suboptimal. We aimed to evaluate whether coronary artery calcium score (CAC) may rule out obstructive coronary artery disease (CAD) pre-TAVI. TAVI candidates (n = 230; mean age 80 ± 8 years), 49% men, underwent preprocedural CTA and invasive coronary angiography. Obstructive CAD was defined as luminal diameter stenosis of ≥50% of left main or 3 major vessels ≥70%. Vessels with coronary stents or bypass were excluded. CAC score was calculated using the Agatston method. Receiver operating characteristic was applied to establish the CAC threshold for obstructive CAD. Multivariable analysis with adjustment for clinical covariates was applied. Net reclassification for nonobstructive disease using CAC score was calculated among nondiagnostic CT scans. Median CAC score was 1,176 (interquartile range 613 to 1,967). Receiver operating characteristic analysis showed high negative predictive value (NPV) for obstructive CAD as follows: left main CAC score 252, NPV 99%; left anterior descending CAC score 250, NPV 97%; left circumflex CAC score 297, NPV 92%; and right coronary artery CAC score 250, NPV 91%. Multivariate analysis showed the highest tertile of CAC score (≥1,670) to be an independent predictor of obstructive CAD (odds ratio 10.7, 95% confidence interval 4.6 to 25, p <0.001). Among nondiagnostic CTA, net reclassification showed reclassification of 76%, 13%, 45%, and 34% of left main, left anterior descending, left circumflex, and right coronary artery for nonobstructive CAD, respectively. In conclusion, CAC score cutoffs can be used to predict nonobstructive CAD. Implementing CAC score on pre-TAVI imaging can reduce a significant proportion of invasive coronary angiography.

Identifiants

pubmed: 36115727
pii: S0002-9149(22)00852-9
doi: 10.1016/j.amjcard.2022.07.030
pii:
doi:

Substances chimiques

Calcium SY7Q814VUP

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

70-77

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Auteurs

Sharon Shalom Natanzon (SS)

Heart Institute, Sheba Medical Center, Tel HaShomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Alexander Fardman (A)

Heart Institute, Sheba Medical Center, Tel HaShomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Israel Mazin (I)

Heart Institute, Sheba Medical Center, Tel HaShomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Israel Barbash (I)

Heart Institute, Sheba Medical Center, Tel HaShomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Amit Segev (A)

Heart Institute, Sheba Medical Center, Tel HaShomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Eli Konen (E)

Department of Diagnostic Imaging, Sheba Medical Center, Tel HaShomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Orly Goitein (O)

Department of Diagnostic Imaging, Sheba Medical Center, Tel HaShomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Victor Guetta (V)

Heart Institute, Sheba Medical Center, Tel HaShomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Ehud Raanani (E)

Department of Cardiac Surgery, Sheba Medical Center, Tel HaShomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Elad Maor (E)

Heart Institute, Sheba Medical Center, Tel HaShomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Yafim Brodov (Y)

Heart Institute, Sheba Medical Center, Tel HaShomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Diagnostic Imaging, Sheba Medical Center, Tel HaShomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. Electronic address: yafim.brodov@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH